Elos Medtech AB (publ) reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was SEK 269.8 million compared to SEK 233.1 million a year ago. Net income was SEK 9.4 million compared to SEK 29.7 million a year ago. Basic earnings per share from continuing operations was SEK 1.16 compared to SEK 3.68 a year ago.
For the six months, sales was SEK 537 million compared to SEK 427.6 million a year ago. Net income was SEK 32.9 million compared to SEK 52.7 million a year ago. Basic earnings per share from continuing operations was SEK 4.07 compared to SEK 6.53 a year ago.